Genoil Inc. Files 6-K for Q3 2024

Ticker: GNOLF · Form: 6-K · Filed: Nov 19, 2024 · CIK: 1261002

Genoil INC 6-K Filing Summary
FieldDetail
CompanyGenoil INC (GNOLF)
Form Type6-K
Filed DateNov 19, 2024
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: reporting, 6-K, oil-gas

TL;DR

GENOIL INC. filed its Q3 2024 6-K. Standard reporting update.

AI Summary

Genoil Inc. filed a Form 6-K for the period ending September 30, 2024. The company, incorporated in New York, operates in the Oil, Gas Field Services sector. Its principal executive offices are located at One Rockefeller Plaza, 11th Floor, New York, NY. Genoil Inc. is required to file annual reports under Form 20-F.

Why It Matters

This filing provides an update on Genoil Inc.'s reporting status and operational details for the third quarter of 2024, which is crucial for investors tracking the company's compliance and business activities.

Risk Assessment

Risk Level: low — This is a routine periodic filing (6-K) that does not contain new material financial information or significant corporate events.

Key Players & Entities

FAQ

What is the reporting period for this Form 6-K filing?

The reporting period for this Form 6-K is the period ending September 30, 2024.

What is the company's name and SEC file number?

The company's name is GENOIL INC. and its SEC file number is 000-50766.

Where are Genoil Inc.'s principal executive offices located?

Genoil Inc.'s principal executive offices are located at One Rockefeller Plaza, 11th Floor, New York, NY.

Does Genoil Inc. file annual reports under Form 20-F or Form 40-F?

Genoil Inc. files annual reports under cover of Form 20-F.

What is the Standard Industrial Classification for Genoil Inc.?

The Standard Industrial Classification for Genoil Inc. is OIL, GAS FIELD SERVICES, NBC [1389].

Filing Stats: 384 words · 2 min read · ~1 pages · Grade level 15.6 · Accepted 2024-11-18 20:32:28

Filing Documents

Financial Statements

Financial Statements 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Genoil Inc. (Registrant) Date: November 18, 2024 By: /s/ David Lifschultz Name: David Lifschultz Title: CEO 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing